Collection of Circulating Biomarkers in Pancreatic Cancer

Part of paid clinical trials in Philadelphia, Pennsylvania.

Sponsor
Abramson Cancer Center at Penn Medicine
Study ID
NCT05743049
Status
Recruiting
Apply to this trial

Conditions

  • Pancreas Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Obtaining blood for analysis of various circulating biomarkers — OTHER
    4 tbsp of blood in a 1-week period, occurring no more frequently than 4 times in an 8-week period

Study Details

This protocol will involve collection of blood samples from patients with a diagnosis of pancreatic adenocarcinoma for evaluation of circulating biomarkers.

Key Dates

Start date
Feb 27, 2023
Status verified
Apr 2026
Primary completion
Jun 30, 2027
Completion
Jan 15, 2028

Study Design

Enrollment
30 participants (estimated)

Arms

  • Arm: Blood specimens
    Collection of blood for analysis of various circulating biomarkers in patients with pancreatic adenocarcinoma.

Primary Outcome Measure

To create a comprehensive system to collect, catalogue and store blood specimens from subjects with pancreatic cancer for future research use. [ Time Frame: Through study completion, an average of 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Abramson Cancer Center at University of PennsylvaniaPhiladelphiaPennsylvania19104-

Find similar trials in Philadelphia, PA

By research site
Abramson Cancer Center at University of Pennsylvania· Philadelphia, PA

Related Studies